# Alaunos Therapeutics, Inc.: filings

TCRT · Nasdaq · CIK 1107421 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tcrt.md) · [Financials](/companies/tcrt/financials.md) · [Filings](/companies/tcrt/filings.md) · [Insiders](/companies/tcrt/insiders.md)

## Reports and events: 433 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 346, 8-K 309, 10-Q 53, SC 13G/A 45, 3 37, DEFA14A 32, 10-K 18, 424B5 18, DEF 14A 17, SC 13G 17, UPLOAD 17, DFAN14A 16, CORRESP 14, SC 13D/A 11, S-8 10, 424B3 9, D 8, S-3 8, EFFECT 7, S-3/A 7, 10-K/A 6, CT ORDER 6, PRE 14A 6, SCHEDULE 13D/A 6, 8-K/A 5, SCHEDULE 13D 4, 4/A 3, PRRN14A 3, 10-Q/A 2, 144 2, 424B7 2, ARS 2, DEFC14A 2, FWP 2, PREC14A 2, S-3ASR 2, SCHEDULE 13G/A 2, SEC STAFF LETTER 2, 424B8 1, 5 1, DFRN14A 1, NT 10-Q 1, PRER14A 1, S-1 1, S-3MEF 1, SC 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:30 ET | [8-K](/filings/0001193125-26-430507.md) | 8.01 Other events | 0001193125-26-430507 |
| 2026-10-21 | 20:30 ET | [8-K](/filings/0001193125-26-427890.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-427890 |
| 2026-10-15 | 23:55 ET | [SCHEDULE 13D/A](/filings/0001193805-26-001370.md) | Ownership report, active investor, amended | 0001193805-26-001370 |
| 2026-10-15 | 20:01 ET | [SCHEDULE 13D](/filings/0001683168-26-007898.md) | Ownership report, active investor | 0001683168-26-007898 |
| 2026-10-13 | 13:28 ET | [8-K](/filings/0001193125-26-419829.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-419829 |
| 2026-10-09 | 20:30 ET | [8-K](/filings/0001193125-26-419154.md) | 3.01 Delisting notice | 0001193125-26-419154 |
| 2026-09-22 | 20:30 ET | [8-K](/filings/0001193125-26-397996.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-397996 |
| 2026-09-17 | 01:03 ET | [8-K](/filings/0001193125-26-393462.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws | 0001193125-26-393462 |
| 2026-08-14 | 20:31 ET | [10-Q](/filings/0001193125-26-352421.md) | Quarterly report, period 2026-06-30 | 0001193125-26-352421 |
| 2026-06-29 | 12:30 ET | [8-K](/filings/0001193125-26-286914.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-286914 |
| 2026-05-26 | 15:00 ET | [8-K](/filings/0001193125-26-238237.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-238237 |
| 2026-05-18 | 12:00 ET | [8-K](/filings/0001193125-26-227921.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-227921 |
| 2026-05-15 | 21:29 ET | [10-Q](/filings/0001193125-26-227272.md) | Quarterly report, period 2026-03-31 | 0001193125-26-227272 |
| 2026-04-30 | 21:14 ET | [10-K/A](/filings/0001193125-26-197838.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-197838 |
| 2026-04-15 | 20:32 ET | [8-K](/filings/0001193125-26-157126.md) | 3.01 Delisting notice | 0001193125-26-157126 |
| 2026-03-31 | 20:33 ET | [10-K](/filings/0001193125-26-134720.md) | Annual report, period 2025-12-31 | 0001193125-26-134720 |
| 2026-03-05 | 16:33 ET | [SCHEDULE 13D/A](/filings/0002094682-26-000002.md) | Ownership report, active investor, amended | 0002094682-26-000002 |
| 2026-03-02 | 11:29 ET | [8-K](/filings/0001193125-26-084084.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-084084 |
| 2026-02-24 | 21:56 ET | [SCHEDULE 13D/A](/filings/0002094682-26-000001.md) | Ownership report, active investor, amended | 0002094682-26-000001 |
| 2026-01-08 | 13:30 ET | [8-K](/filings/0001193125-26-007054.md) | 1.02 Termination of a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-007054 |
| 2025-12-23 | 22:18 ET | [8-K](/filings/0001193125-25-331147.md) | 8.01 Other events | 0001193125-25-331147 |
| 2025-12-05 | 20:20 ET | [SCHEDULE 13D/A](/filings/0002094682-25-000003.md) | Ownership report, active investor, amended | 0002094682-25-000003 |
| 2025-11-14 | 21:15 ET | [10-Q](/filings/0001193125-25-282988.md) | Quarterly report, period 2025-09-30 | 0001193125-25-282988 |
| 2025-10-31 | 18:13 ET | [SCHEDULE 13D/A](/filings/0002094682-25-000002.md) | Ownership report, active investor, amended | 0002094682-25-000002 |
| 2025-10-30 | 22:48 ET | [SCHEDULE 13D](/filings/0002094682-25-000001.md) | Ownership report, active investor | 0002094682-25-000001 |
| 2025-10-22 | 23:25 ET | [S-1](/filings/0001193125-25-245483.md) | Registration statement | 0001193125-25-245483 |
| 2025-09-05 | 21:20 ET | [SCHEDULE 13D/A](/filings/0001213900-25-085149.md) | Ownership report, active investor, amended | 0001213900-25-085149 |
| 2025-08-20 | 21:15 ET | [8-K](/filings/0000950170-25-110484.md) | 8.01 Other events | 0000950170-25-110484 |
| 2025-08-14 | 20:15 ET | [10-Q](/filings/0000950170-25-108887.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108887 |
| 2025-07-22 | 20:45 ET | [8-K](/filings/0000950170-25-097591.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-097591 |
| 2025-07-17 | 21:12 ET | [8-K](/filings/0000950170-25-096656.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-096656 |
| 2025-07-10 | 20:30 ET | [8-K](/filings/0000950170-25-095029.md) | 3.03 Change to security holders’ rights; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-095029 |
| 2025-07-02 | 21:30 ET | [8-K](/filings/0000950170-25-093263.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0000950170-25-093263 |
| 2025-07-01 | 23:40 ET | [SCHEDULE 13D](/filings/0000921895-25-001912.md) | Ownership report, active investor | 0000921895-25-001912 |
| 2025-06-26 | 12:45 ET | [8-K](/filings/0000950170-25-090202.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-090202 |
| 2025-06-26 | 12:45 ET | [8-K](/filings/0000950170-25-090201.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-090201 |
| 2025-06-10 | 21:52 ET | [8-K](/filings/0000950170-25-083913.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-083913 |
| 2025-05-23 | 21:00 ET | [8-K](/filings/0000950170-25-077064.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-077064 |
| 2025-05-21 | 12:42 ET | [DEF 14A](/filings/0001193125-25-123677.md) | Proxy statement, period 2025-07-03 | 0001193125-25-123677 |
| 2025-05-15 | 20:27 ET | [10-Q](/filings/0000950170-25-072709.md) | Quarterly report, period 2025-03-31 | 0000950170-25-072709 |
| 2025-05-14 | 18:59 ET | [SCHEDULE 13D](/filings/0001213900-25-043211.md) | Ownership report, active investor | 0001213900-25-043211 |
| 2025-04-30 | 20:59 ET | [10-K/A](/filings/0000950170-25-061207.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-061207 |
| 2025-04-18 | 20:45 ET | [8-K](/filings/0000950170-25-055903.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-055903 |
| 2025-04-15 | 21:00 ET | [8-K](/filings/0000950170-25-054309.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-054309 |
| 2025-04-14 | 13:15 ET | [8-K](/filings/0000950170-25-053523.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-053523 |
| 2025-04-11 | 20:45 ET | [8-K](/filings/0000950170-25-053325.md) | 3.01 Delisting notice; 8.01 Other events | 0000950170-25-053325 |
| 2025-03-31 | 20:18 ET | [10-K](/filings/0000950170-25-047758.md) | Annual report, period 2024-12-31 | 0000950170-25-047758 |
| 2024-11-14 | 14:30 ET | [10-Q](/filings/0000950170-24-126793.md) | Quarterly report, period 2024-09-30 | 0000950170-24-126793 |
| 2024-10-10 | 12:30 ET | [8-K](/filings/0000950170-24-113960.md) | 1.02 Termination of a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-113960 |
| 2024-08-14 | 20:54 ET | [10-Q](/filings/0000950170-24-097142.md) | Quarterly report, period 2024-06-30 | 0000950170-24-097142 |

Page 1 of 9. [Older](/companies/tcrt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.